by Pavel Zhelev | Mar 8, 2022 | Events
Once again, due to COVID -19 Pandemic, Microbix will be hosting a virtual AGM on March 30, 2022 at 1:00 pm. The online link will allow shareholders to listen to the AGM and view a CEO presentation via Zoom. Shareholders without up-to-date computer access can...
by Microbix | Mar 3, 2022 | Events
The time has come again for the Canadian annual meeting in infectious diseases and diagnostic microbiology. The AMMI Canada – CACMID Annual Conference is returning in a hybrid format: in-person in Vancouver, BC, and online via our virtual platform. The AMMI Canada –...
by Microbix | Mar 3, 2022 | Events
The EUROGIN 2022 Organizing Committee is happy to welcome the HPV community to gather again in person in Düsseldorf on April 10-12, 2022, after a difficult period owing to the COVID-19 pandemic. EUROGIN Conference 2022 is the first large international in-person...
by Pavel Zhelev | Oct 6, 2021 | Events
Advanced SARS-CoV-2 Variants of Concern (VOC) whole genome materials for use as verification, external quality assessment (EQA) and prospective quality control samples Click below to download the poster:
by Pavel Zhelev | Sep 23, 2021 | Events
Meetings with Growth-Oriented Investors, September 24-26, 2021 MISSISSAUGA, September 23, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it will be presenting to investors at the...
by Pavel Zhelev | Jul 16, 2021 | Events
Two Posters Reporting on Cross-Platform Utility of Antigen & Serological QAPs™ Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective Quality Controls Advanced SARS-CoV-2 nucleocapsid...
Request a Quote
+1803294983432
customer.service@microbix.com